• Adding the popular Pay Per Procedure business model to the MiraQ platform

    Medistim utilizes several business models to effectively reach different segments of the US market. In addition to traditional capital investments and purchase of consumables, hospitals can choose to enter leasing agreements or Pay Per Procedure…

    Read more
  • Results for the First Quarter 2021

    Sales for the quarter ended at MNOK 102.6 (MNOK 103.1), on par with the sales record set in Q1 last year. Currency neutral, sales increased by 1.5%. Second best quarter ever for operating result (EBIT)…

    Read more
  • Annual Report 2020

    Following a good start to the year, Medistim experienced a significant impact on operations in the first months of the pandemic. However, due to a solid revenue base and good pipeline activity throughout the second…

    Read more
  • Results for the Fourth Quarter and Preliminary Results for 2020

    Sales for the quarter ended at MNOK 94.2 (MNOK 95.7), a decrease of 1.6%. Sales for 2020 ended at MNOK 363.1 (MNOK 363.7). Operating result (EBIT) for the quarter ended at MNOK 22.1 (MNOK 19.7)…

    Read more
  • Medistim partners with LivaNova as their new distributor for India

    With its population size of about 1,4 billion, India is a large and emerging market for Medistim’s ultrasound devices.  Today, about 100,000 coronary bypass (CABG) procedures are performed in India annually, representing a market size…

    Read more
  • Results for the Third Quarter 2020

    Sales for the quarter ended at MNOK 83.4 (MNOK 85.5), a decrease of 2,5%. Read the full report and presentation below. Q3 report 2020 Q3 presentation 2020

    Read more
  • Webinar: Third Quarter Financial Results

    Sign up for the upcoming financial report presentation. You're invited to join this presentation on Thursday 22 October at 8 AM CEST. CEO Kari E. Krogstad and CFO Thomas Jakobsen will present the third quarter results,…

    Read more
  • Results for the Second Quarter and First Half 2020

    Sales for the quarter ended at MNOK 82.5 (MNOK 93.8), a decrease of 12.2%. Sales for the 1st half ended at MNOK 185.6 (MNOK 182.5), a 1.7 % increase. Read the full report and presentation…

    Read more
  • Webinar: Second Quarter and Half-yearly Financial Report

    Sign up for the upcoming financial report presentation. You're invited to join this presentation on Friday 14 August at 8 AM CEST. CEO Kari E. Krogstad and CFO Thomas Jakobsen will present the second quarter and…

    Read more
  • Results for the First Quarter 2020

    Sales for the quarter ended at a record high MNOK 103.1 (MNOK 88.7), a 16.2% increase.This was driven by strong growth in capital sales of systems in Japan after regulatory approval of MiraQ™. Read the…

    Read more